Weicong Liu,Qianwen Yan,Chen Xia,Xiaoxiong Wang,Abhinav Kumar,Yan Wang,Yiwei Liu,Ying Pan,Jianqiang Liu
Abstract:In the presented perspective, the synthetic method, characterization, and research progress in tumor therapy based on CMMs have been summarized. Also the prospects and challenges of utilizing CMMs for tumor therapy have been discussed.
What problem does this paper attempt to address?
The paper primarily discusses the application of Metal-Organic Frameworks (MOFs) in tumor therapy, particularly through the enhancement of MOFs' tumor targeting and immune evasion capabilities using cell membrane coating technology. The following are the key issues the paper attempts to address:
1. **Improving MOFs' Tumor Targeting**: MOFs, as a novel type of hybrid crystalline porous biomaterial, have shown great potential in fields such as sensing, photocatalysis, gas adsorption/separation, and biomedicine. However, once injected into the bloodstream, they are easily recognized and degraded by the immune system, which limits their application in tumor therapy.
2. **Avoiding Clearance by the Immune System**: Monofunctional MOFs encounter the adsorption of proteins and cellular components in the blood, leading to changes in their physicochemical properties. This not only causes adverse side effects but also reduces therapeutic efficacy. Even with surface modifications that endow MOFs with biocompatibility, active or passive targeting capabilities, and extended circulation time, these modifications still face issues of degradation, immune recognition, and removal.
3. **Enhancing Drug Delivery Efficiency**: Synthetic composite materials, as foreign substances, are easily recognized and eliminated by the immune system, resulting in short half-lives for most synthetic MOF carriers and difficulty in accumulating at lesion sites. Therefore, an ideal drug carrier needs to possess biocompatibility, stability, and targeting capabilities.
To overcome these challenges, researchers have explored an emerging bio-interface approach—cell membrane coating technology, which involves wrapping MOFs with different types of cell membranes (such as red blood cells, immune cells, cancer cells, platelets, etc.), allowing MOFs to inherit the physicochemical properties and biological functions of the cell membranes. This achieves immune evasion, long-term circulation, targeted delivery, and controlled drug release. This method, through biomimetic technology, endows MOFs with cell membrane-like characteristics, enabling them to evade recognition and clearance by the immune system while also achieving effective drug delivery and controlled release, thereby enhancing anti-tumor therapeutic effects.
The paper also summarizes the synthetic methods, characterization techniques, and research progress in the field of tumor therapy based on cell membrane-coated MOFs (CMMs), and discusses the future prospects and challenges faced by this field. By integrating the advantages of cell membranes and MOFs, biomimetic MOF carriers can exhibit stronger targeting performance and anti-tumor effects. In addition, the paper introduces specific application examples of different types of cell membrane-coated MOFs in tumor therapy, including chemotherapy, photothermal therapy, and photodynamic therapy, demonstrating the broad application prospects of this technology in the field of tumor therapy.